Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Add To Watchlist

Recent & Breaking News (NDAQ:AEMD)

Aethlon Medical (AEMD) CEO Note: Hemopurifier Clinical Progression, USA Today on the Next Zika, Combating Bioterror & Pandemic Threats

PR Newswire May 2, 2016

FinancialBuzz.com Exclusive NASDAQ MarketSite Interview with Aethlon Medical, Inc. CEO James Joyce

PR Newswire April 5, 2016

Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements

PR Newswire March 31, 2016

Aethlon Medical, Inc. Reports Annual Meeting Results

PR Newswire March 30, 2016

Aethlon Medical To Present At Roth Capital Partners 28th Annual Growth Stock Conference On March 16, 2016

PR Newswire March 9, 2016

Aethlon Medical's Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) During Life

PR Newswire February 25, 2016

Aethlon Medical To Present At 4th Annual Sachs Cancer Bio Partnering & Investment Forum On February 24, 2016

PR Newswire February 18, 2016

Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016

PR Newswire February 5, 2016

Aethlon Medical Announces Fiscal 2016 Third Quarter Results

PR Newswire February 4, 2016

Aethlon Medical Announces Dengue Virus Study Approval, Chikungunya Virus Capture Data and Completion of U.S. Principal Investigator Training

PR Newswire February 3, 2016

Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference

PR Newswire February 1, 2016

Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016

PR Newswire January 29, 2016

Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

PR Newswire January 12, 2016

Four Companies Involved in the Diagnosis, Treatment, and Prevention of CTE

Accesswire January 5, 2016

Aethlon Medical's CEO Jim Joyce Interviewed by The Life Sciences Report

Marketwired December 23, 2015

Equity Market Movement at a Glance - Research on Aethlon Medical, Famous Dave's of America, ID Systems and AgroFresh Solutions

Accesswire December 4, 2015

Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

PR Newswire November 10, 2015

SeeThruEquity's Ajay Tandon and Jay Albany Interviewed by The Life Sciences Report

Marketwired October 29, 2015

Aethlon Medical's James Joyce Interviewed by The Life Sciences Report

Marketwired October 29, 2015

Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

PR Newswire October 26, 2015